In an effort to retain its early lead in the rapidly growing digital PCR arena, Fluidigm is developing versions of its Digital Array PCR chips that will enable "hundreds of thousands" of PCR reactions to be performed in parallel, a company executive said this week.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.